EcoR1 Capital
Latest statistics and disclosures from EcoR1 Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PRTA, MORF, ANAB, RCUS, XNCR, and represent 54.63% of EcoR1 Capital's stock portfolio.
- Added to shares of these 10 stocks: GLPG (+$82M), RCUS (+$62M), BPMC (+$26M), PTGX (+$26M), DRNA (+$25M), GRTS (+$23M), ALEC (+$17M), Tango Therapeutics (+$17M), RNA (+$16M), BLUE (+$15M).
- Started 12 new stock positions in BPMC, VYGR, Tango Therapeutics, BLUE, IMVT, DRNA, Erasca, PTGX, Caribou Biosciences, Surrozen. GLPG, SRRK.
- Reduced shares in these 10 stocks: RLAY (-$98M), Translate Bio (-$29M), NRIX (-$25M), KYMR (-$25M), ARVN (-$25M), BCEL (-$21M), SBTX (-$14M), KDNY (-$13M), ACIU (-$13M), NLTX (-$11M).
- Sold out of its positions in ALVR, ARVN, BCEL, Bctg Acquisition Corp, KDNY, FSTX, KYMR, MGTA, SYRS, Translate Bio. ZNTL, Consonance Hfw Acquisition A, Consonance Hfw Acquisition A.
- EcoR1 Capital was a net buyer of stock by $64M.
- EcoR1 Capital has $2.9B in assets under management (AUM), dropping by 7.43%.
- Central Index Key (CIK): 0001587114
Tip: Access up to 7 years of quarterly data
Positions held by EcoR1 Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for EcoR1 Capital
Companies in the EcoR1 Capital portfolio as of the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Prothena Corp SHS (PRTA) | 28.0 | $804M | 11M | 71.23 | ||
| Morphic Hldg (MORF) | 7.8 | $224M | 4.0M | 56.64 | ||
| Anaptysbio Inc Common (ANAB) | 7.1 | $204M | 7.5M | 27.12 | ||
| Arcus Biosciences Incorporated (RCUS) | 6.2 | $179M | +53% | 5.1M | 34.87 | |
| Xencor (XNCR) | 5.6 | $160M | 4.9M | 32.66 | ||
| Nuvation Bio Com Cl A (NUVB) | 4.7 | $136M | 14M | 9.94 | ||
| Alector (ALEC) | 4.0 | $114M | +17% | 5.0M | 22.82 | |
| Mirati Therapeutics (MRTX) | 2.9 | $82M | 464k | 176.91 | ||
| Galapagos Nv Spon Adr (GLPG) | 2.9 | $82M | NEW | 1.6M | 52.61 | |
| Shattuck Labs (STTK) | 2.6 | $76M | +11% | 3.7M | 20.38 | |
| Oric Pharmaceuticals (ORIC) | 2.5 | $73M | +12% | 3.5M | 20.91 | |
| Kura Oncology (KURA) | 2.4 | $70M | 3.7M | 18.73 | ||
| Avidity Biosciences Ord (RNA) | 2.4 | $68M | +31% | 2.8M | 24.63 | |
| Gritstone Oncology Ord (GRTS) | 2.1 | $60M | +62% | 5.6M | 10.80 | |
Setup an alertEcoR1 Capital will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Relay Therapeutics (RLAY) | 1.5 | $44M | -69% | 1.4M | 31.53 | |
| Iteos Therapeutics (ITOS) | 1.2 | $35M | +25% | 1.3M | 27.00 | |
| Nurix Therapeutics (NRIX) | 1.2 | $34M | -42% | 1.1M | 29.96 | |
| Janux Therapeutics (JANX) | 1.1 | $31M | 1.4M | 21.63 | ||
| Design Therapeutics (DSGN) | 1.0 | $27M | +47% | 1.9M | 14.69 | |
| Blueprint Medicines Call Option (BPMC) | 0.9 | $26M | NEW | 250k | 103.73 | |
| Protagonist Therapeutics (PTGX) | 0.9 | $26M | NEW | 1.4M | 17.72 | |
| Dicerna Pharmaceuticals (DRNA) | 0.9 | $25M | NEW | 1.2M | 20.16 | |
| Akouos (AKUS) | 0.8 | $23M | 2.0M | 11.61 | ||
| Solid Biosciences (SLDB) | 0.8 | $22M | 9.2M | 2.39 | ||
| Edgewise Therapeutics (EWTX) | 0.7 | $21M | +4% | 1.3M | 16.60 | |
| Ovid Therapeutics (OVID) | 0.7 | $20M | 6.1M | 3.36 | ||
| Tango Therapeutics Com Added | 0.6 | $17M | NEW | 1.3M | 12.93 | |
| Bluebird Bio (BLUE) | 0.5 | $15M | NEW | 803k | 19.11 | |
| Erasca Com Added | 0.5 | $15M | NEW | 700k | 21.22 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.4 | $13M | 755k | 16.70 | ||
| Silverback Therapeutics (SBTX) | 0.4 | $12M | -54% | 1.2M | 9.98 | |
| Odonate Therapeutics Ord (ODT) | 0.4 | $11M | +348% | 3.7M | 2.91 | |
| Corvus Pharmaceuticals (CRVS) | 0.4 | $10M | -41% | 2.1M | 4.84 | |
| Immunovant (IMVT) | 0.3 | $9.9M | NEW | 1.1M | 8.69 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.3 | $9.6M | 963k | 9.94 | ||
| C4 Therapeutics Com Stk (CCCC) | 0.3 | $8.9M | 200k | 44.68 | ||
| Kronos Bio (KRON) | 0.3 | $8.1M | 387k | 20.96 | ||
| Neoleukin Therapeutics (NLTX) | 0.2 | $6.2M | -63% | 861k | 7.23 | |
| Frazier Lifesciences Acqu SHS (FLAC) | 0.2 | $5.8M | +193% | 588k | 9.82 | |
| Ac Immune Sa SHS (ACIU) | 0.2 | $5.0M | -71% | 751k | 6.71 | |
| Ngm Biopharmaceuticals Call Option (NGM) | 0.2 | $5.0M | +70% | 245k | 20.41 | |
| Cyclerion Therapeutics (CYCN) | 0.2 | $4.9M | 1.6M | 3.07 | ||
| Jiya Acquisition Corp Com Cl A (JYAC) | 0.2 | $4.9M | 500k | 9.75 | ||
| Verve Therapeutics (VERV) | 0.2 | $4.7M | 100k | 47.00 | ||
| Kinnate Biopharma (KNTE) | 0.1 | $4.0M | +600% | 175k | 23.02 | |
| Health Sciences Acq Corp 2 Ord SHS (HSAQ) | 0.1 | $4.0M | 400k | 9.89 | ||
| Fs Development Corp Ii Com Cl A (FSII) | 0.1 | $3.7M | +147% | 371k | 9.95 | |
| Dyne Therapeutics (DYN) | 0.1 | $3.6M | 215k | 16.60 | ||
| Igm Biosciences (IGMS) | 0.1 | $2.5M | 38k | 65.76 | ||
| Forma Therapeutics Hldgs SHS (FMTX) | 0.1 | $2.1M | -14% | 90k | 23.19 | |
| Bcls Acquisition Corp Com Cl A (BLSA) | 0.1 | $2.0M | 200k | 9.96 | ||
| Helix Acquisition Corp Com Cl A (HLXA) | 0.1 | $2.0M | 200k | 9.95 | ||
| 5 01 Acquisition Corp Com Cl A (FVAM) | 0.1 | $2.0M | 200k | 9.82 | ||
| Eucrates Biomedical Acqu Cor SHS (EUCR) | 0.1 | $2.0M | 200k | 9.78 | ||
| Bolt Biotherapeutics (BOLT) | 0.1 | $1.8M | 150k | 12.32 | ||
| Caribou Biosciences Com Added | 0.1 | $1.8M | NEW | 75k | 23.87 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $1.5M | 150k | 10.05 | ||
| Pmv Pharmaceuticals (PMVP) | 0.1 | $1.5M | 50k | 29.80 | ||
| Bioatla (BCAB) | 0.1 | $1.5M | 50k | 29.44 | ||
| Repare Therapeutics Ord (RPTX) | 0.0 | $1.3M | 50k | 25.72 | ||
| Meiragtx Holdings (MGTX) | 0.0 | $1.2M | 95k | 13.18 | ||
| Voyager Therapeutics (VYGR) | 0.0 | $1.2M | NEW | 446k | 2.63 | |
| Caremax *w Exp 06/08/202 (CMAXW) | 0.0 | $986k | 100k | 9.86 | ||
| Turmeric Acquisition Corp Cl A (TMPM) | 0.0 | $979k | 100k | 9.79 | ||
| Frazier Lifesciences Acqu *w Exp 11/30/202 (FLACW) | 0.0 | $655k | 67k | 9.83 | ||
| Eucrates Biomedical Acqu Cor *w Exp 10/23/202 (EUCRW) | 0.0 | $652k | 67k | 9.78 | ||
| Omega Alpha Spac Cl A (OMEG) | 0.0 | $487k | 50k | 9.74 | ||
| Surrozen *w Exp 10/28/2025 | 0.0 | $471k | NEW | 67k | 7.07 | |
| Turmeric Acquisition Corp *w Exp 10/08/202 (TMPMW) | 0.0 | $326k | 33k | 9.78 | ||
| Scholar Rock Hldg Corp (SRRK) | 0.0 | $271k | NEW | 8.2k | 33.02 | |
| Alpine Immune Sciences (ALPN) | 0.0 | $75k | -98% | 7.0k | 10.71 | |
Past Filings by EcoR1 Capital
SEC 13F filings are viewable for EcoR1 Capital going back to 2014
- EcoR1 Capital 2021 Q3 restated filed Nov. 22, 2021
- EcoR1 Capital 2021 Q2 filed Aug. 16, 2021
- EcoR1 Capital 2021 Q1 filed May 17, 2021
- EcoR1 Capital 2020 Q4 filed Feb. 16, 2021
- EcoR1 Capital 2020 Q3 filed Nov. 16, 2020
- EcoR1 Capital 2020 Q2 filed Aug. 14, 2020
- EcoR1 Capital 2020 Q1 filed May 15, 2020
- EcoR1 Capital 2019 Q4 restated filed Feb. 18, 2020
- EcoR1 Capital 2019 Q4 filed Feb. 14, 2020
- EcoR1 Capital 2019 Q3 filed Nov. 14, 2019
- EcoR1 Capital 2019 Q2 filed Aug. 14, 2019
- EcoR1 Capital 2019 Q1 filed May 15, 2019
- EcoR1 Capital 2018 Q4 filed Feb. 14, 2019
- EcoR1 Capital 2018 Q3 filed Nov. 14, 2018
- EcoR1 Capital 2018 Q2 filed Aug. 14, 2018
- EcoR1 Capital 2018 Q1 filed May 15, 2018